
Carima showcased the ZENESIS bio-3D printer featuring a direct-to-glass printing technique that maintains over 90% cell viability.
Originally reported by AMEnews
Carima showcased the ZENESIS bio-3D printer featuring a direct-to-glass printing technique that maintains over 90% cell viability. The system produces 300 samples per minute, representing a 144x productivity leap over manual methods and reducing labor costs by 20%. By integrating freeze-dried EZ-preBioink capsules, the platform eliminates traditional bio-ink instability and preparation bottlenecks. This advancement signals a shift toward industrial-grade automated bio-fabrication for high-throughput drug screening and organ-on-a-chip research. 馃К馃敩
This article is an AI-assisted rewrite of the linked source report. Facts originate from the source; phrasing is AMPulse's. Use Read Original below to verify, or Report an issue if something is wrong.